Chelsea Therapeutics International Liabilities:
3.096M for March 31, 2013Chelsea Therapeutics International Historical Liabilities Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 3.096M |
| Dec. 31, 2012 | 3.011M |
| Sept. 30, 2012 | 6.113M |
| June 30, 2012 | 8.724M |
| March 31, 2012 | 12.45M |
| Dec. 31, 2011 | 13.24M |
| Sept. 30, 2011 | 13.64M |
| June 30, 2011 | 12.68M |
| March 31, 2011 | 16.12M |
| Dec. 31, 2010 | 13.19M |
| Sept. 30, 2010 | 9.578M |
| June 30, 2010 | 9.370M |
| March 31, 2010 | 19.87M |
| Dec. 31, 2009 | 21.50M |
| Sept. 30, 2009 | 23.84M |
| June 30, 2009 | 24.23M |
| March 31, 2009 | 22.46M |
| Dec. 31, 2008 | 19.58M |
| Sept. 30, 2008 | 9.526M |
| June 30, 2008 | 8.500M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Jan. 31, 2005 | Go Pro |
| Oct. 31, 2004 | Go Pro |
| July 31, 2004 | Go Pro |
| April 30, 2004 | Go Pro |
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.
Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.
Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More
CHTP Liabilities Benchmarks
| Companies | |
|---|---|
| Achillion Pharmaceuticals | 10.84M |
| Merrimack Pharmaceuticals | 155.49M |
| Vanda Pharmaceuticals | 125.54M |
CHTP Liabilities Rankings
| Overall |
92nd percentile 628 of 8002 |
| Sector |
87th percentile 84 of 650 in Healthcare |
| Industry |
83rd percentile 39 of 237 in Biotechnology |
CHTP Liabilities Range, Past 5 Years
| Minimum | 3.011M | Dec 2012 |
| Maximum | 24.23M | Jun 2009 |
| Average | 13.54M |
